Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Topic

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.

May 20, 2017

As cases of cholera and acute watery diarrhea rise across Yemen, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warns that the outbreak is threatening to spiral out of control and calls for an urgent and appropriate response.

May 19, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) has deployed several emergency teams to Niger to contain a meningitis outbreak that has killed 179 people since the beginning of the year. Working closely with Niger’s Ministry of Public Health, MSF teams have vaccinated more than 358,800 people in the most affected areas while continuing to monitor at-risk areas and provide medical care to those affected by the disease. So far, the number of meningitis cases recorded across Niger this year has almost doubled compared to 2016 during the same period.

May 09, 2017

A growing cholera outbreak in Yemen is threatening to spread further in the war-torn country, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, reporting a drastic increase in the number of patients its teams are treating in recent weeks.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

January 24, 2017

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

October 26, 2016

NEW YORK/LIVERPOOL, OCTOBER 26, 2016 – At the annual Union World Conference on Lung Health, which started in Liverpool today, Doctors Without Borders/Médecins Sans Frontières (MSF) is sharing its experience of using the new tuberculosis drugs bedaquiline and delamanid to treat people with drug-resistant TB. MSF is also involved in two clinical trials to test new TB treatments, both of which will start enrolling patients soon.

October 20, 2016

NEW YORK/GENEVA, OCTOBER 20, 2016—A new cholera control strategy using a single-dose oral vaccine instead of two doses could be sufficient in protecting against the deadly disease during an outbreak, according to a study published by international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontiéres (MSF) in the Lancet Global Health this week.

Pages